Background: Survivors of lower extremity (LE) malignancies experience functional deficits. Purpose: The purpose of this prospective clinical trial was to determine feasibility and functional outcomes of adding prehabilitation during the 10-to 12-week period prior to a planned surgery to remove the tumor in children and adolescents with an LE sarcoma. Design: Pilot study. Setting: St. Jude Children's Research Hospital. Patients: Participants included 14 individuals between the ages of 8 and 20 years who had a diagnosis of an LE sarcoma. Participant outcomes were compared with a control group of 35 individuals treated for osteosarcoma who underwent the same functional assessments but no prehabilitation. Intervention: Participants in the intervention group received strengthening exercises and mobility training 3 times per week for 30 to 60 minutes for 10 to 12 weeks preoperatively. Measurements: Participants completed the Functional Mobility Assessment (FMA) and measures of strength and range of motion (ROM) of bilateral LEs at baseline, after 10 to 12 weeks of preoperative physical therapy (PT), and at 20 to 22 weeks. Results: Twelve participants completed at least 50% of their schedule prehabilitative sessions. Participants in the intervention group scored significantly better on the FMA than participants in the control group at weeks 20 to 22 (35.6 vs 25.7, P = .0267). No significant difference was found in ROM or strength. Limitations: Because of this study being a pilot study, the sample size was small. Therefore, we cannot infer generalizability. Conclusions: Findings Rehabilitation Oncology Copyright C 2017 Oncology Section, APTA.
suggest that those with a diagnosis of an LE malignancy awaiting a limb-sparing procedure or amputation participate in at least 50% of scheduled PT sessions and benefit from them. (Rehab Oncol 2017;35:38-45) Key words: adolescents, cancer, exercise, pediatrics, physical therapy, prehabilitation, sarcoma Survivors of childhood cancer are at an increased risk for physical performance limitations and restricted abilities to participate in activities required to fully function in adult social roles. 1 More specifically, functional outcomes for survivors of a lower extremity (LE) malignancy whose treatment required a limb-sparing procedure or amputation are poor. Bekkering and peers 2, 3 evaluated survivors of osteosarcoma and Ewing's sarcoma who had a limbsparing surgery or an ablative surgery. They determined that adolescents who received a limb-savage or ablative surgery had moderate disability according to the Toronto Extremity Salvage Score and Baecke questionnaire as compared with healthy peers. In addition, when compared with their siblings, long-term bone tumor survivors are 2.9 (95% CI, 2.6-3.3) times more likely to report restricted personal skills, 6.3 (95% CI, 4.5-9.0) times more likely to report restricted abilities to participate in routine activities, and 6.8 (95% CI, 5.0-9.3) times more likely to indicate that poor health prevents school or work attendance. 4 Data also indicate that those treated with an LE malignancy are at a 50% increased risk for activity limitations. 5 Because exercise training is known to lead to skeletal muscle adaptations that increase both strength and endurance, 6 addressing existing impairments preoperatively (prehabilitation) may improve postoperative outcomes. Prehabilitation is "a process on the cancer continuum of care that occurs between the time of cancer diagnosis and the beginning of acute treatment and includes physical and psychological assessments that establish a baseline functional level, identify impairments, and provide interventions that promote physical and psychological health to reduce the incidence and/or severity of future impairments." 7(p1) Prehabilitation has shown to reduce the risk of death from disease in adult patients with breast and colorectal cancer. 8, 9 Because previous studies highlight long-term problems with function and mobility among survivors of an LE malignancy who received a limb-sparing procedure or amputation, and because no studies have evaluated the feasibility and functional outcomes of prehabilitation in this patient population, the aims of this study were to determine whether children and adolescents were able to participate in strength and mobility training during 10 to 12 weeks of chemotherapy prior to limb-sparing procedure or amputation. We also evaluated the effect of preoperative exercise training on function at 10 to 12 weeks postoperatively and compared their outcomes with those who did not receive prehabilitation. We hypothesized that 60% of individuals with a malignancy of the LE would be able to participate in at least 50% of their scheduled physical therapy (PT) sessions before receiving a limb-sparing procedure or amputation. In addition, we hypothesized that children who received prehabilitation would demonstrate better functional outcomes both presurgically and at 10 to 12 weeks postoperatively than participants in a historical control group who received no preoperative PT intervention.
METHODS

Setting and Participants
The Institutional Review Boards of St. Jude Children's Research Hospital (SJCRH) approved this study. Written, informed consent was obtained by parents or guardians, and assent was obtained per institutional policy. Participants included 14 children, adolescents, and young adults between the ages of 8 and 20 years with biopsy-confirmed LE malignancies between 2012 and 2016 and who were receiving treatment at SJCRH. Diagnoses included osteosarcoma, Ewing's sarcoma, and an undifferentiated sarcoma involving the soleus muscle. Study exclusion criteria for individuals in the intervention group were those with serious, nonhealing wounds, ulcer or bone fracture (other than pathological fracture), a premorbid condition that prevented the patient from ambulating, and patients whose preoperative chemotherapy period was at least 10 weeks before receiving an amputation or limb-sparing procedure. The control group included 35 age-and gender-matched individuals treated from 2008 to 2012 for LE osteosarcoma at SJCRH. The control group was evaluated at the same time points with the same outcome measures as the intervention group. They did not receive any preoperative PT or prehabilitation but did receive postoperative PT, which is standard of care. There were no differences in medical and surgical management between the 2 groups. Current treatment protocols for LE malignancies typically include 10 to 12 weeks of chemotherapy to decrease the size of tumor, perform local control (eg, limb-sparing procedure or amputation), then continue with chemotherapy for 10 to 12 weeks. 10 Tumor necrosis is the desired outcome of providing chemotherapy preoperatively. 11 Participants were seen both inpatient and outpatient at SJCRH by a licensed physical therapist. See Figure 1 for participants diagram through each stage of study. Of 25 individuals approached, 20 consented to participate and 14 (70%) completed all study assessments (baseline, presurgery, and postsurgery). One participant was deemed to be ineligible after consent, 1 expired before completing all assessments, and 4 withdrew after consenting due to patient deciding against participating in study. One of the participants in the intervention group received 20 weeks of preoperative PT rather than 10 to 12 weeks due to a delay in surgery. 
Intervention
The intervention group received PT 3 times per week for a maximum of 60 minutes each session for 10 to 12 weeks. The therapy sessions included endurance, strengthening, and stretching exercises. Endurance exercise consisted of ambulating with assistive devices as needed, upper extremity (UE) ergometry, and/or playing Wii Sports, which is a video platform that promotes simulation of boxing, bowling, golf, tennis, and baseball. The therapist identified appropriate intensity and duration of the endurance exercise by monitoring heart rate (HR) and/or rate of perceived of exertion (RPE). 12 The desired HR range during exercise was 50% to 70% of their maximum HR. Maximum HR is defined as the difference between 220 and the patient's age. 13 Fifty percent to 70% of age-predicted HR was the goal, but we also used symptom monitoring and RPE to manage PT sessions because individuals with a diagnosis of malignancies and who were receiving chemotherapy might have poor cardiorespiratory fitness. 4 Strengthening exercises involved both UEs and LEs. Participants were first instructed to perform 3 sets of 10 without any resistance, and resistance was as added as appropriate. For UEs, bicep curls, triceps curls, shoulder flexion, and/or press-ups from the therapy mat or wheelchair were included. For the LEs, bridging, long arc quads, hamstring curls, calf raises in standing, single LE squats, and/or dorsiflexion (DF) in the supine position were performed on the uninvolved extremity. Stretching consisted of ankle stretch into DF in the supine or long-sitting position and hamstring stretch in the supine position with hip flexed to 90
• . Stretching was held for 30 to 60 seconds for 2 to 3 sets. 12 Exercise time and resistance were progressed per individual's medical status and per participant's tolerance. Progression was determined by ensuring that participants were reporting 12 to 16 or the "somewhat hard to hard" area on the RPE scale. Participants participated in PT for at least 10 weeks prior to surgery and then 10 to 12 weeks after surgery, which was the usual standard of care. Usual standard of care begins with aggressive PT postoperative day 1. Patients were seen daily while inpatient and once discharged were seen 3 days per week outpatient. Depending on individual progress, frequency of sessions per week may continue at 3 days or may decrease to 1 to 2 days for 10 to 12 weeks. All patients were seen for 30 minutes each session. Treatment sessions included standing, transfer training, gait training, and strengthening and range-of-motion (ROM) exercises for bilateral LEs. PT sessions were modified per patient's precautions (ie, non-weight-bearing, no knee ROM). Subjects were seen by a licensed physical therapist both when inpatient and outpatient. Patients were not seen for PT if platelet count was less than 20 000 mm 3 and/or hemoglobin level was less than 8 g/dL.
14 Participants in the historical control group did not receive any prehabilitation except for gait training with an assistive device and/or to be fit with a knee brace. They received PT postoperatively, which is usual standard of care.
Outcomes
Feasibility was defined as successful if at least 60% of patients were able to complete 50% or more of their scheduled PT sessions, as well as completion of baseline, presurgical, and postsurgical assessment (Table 1) . We used 50% of sessions to indicate success because our previous experience with OS2008 was that children and adolescents did not participate in prehabiliation at all due to the intensity of chemotherapy and the frequency of inpatient hospitalization for chemotherapy-related side effects. With this study, we wanted to keep the threshold low due to the uncertainty of participants being able to attend due to chemotherapyrelated side effects.
The Functional Mobility Assessment (FMA) 15 was used to evaluate physical function. The FMA was validated specifically on children and adolescents with an LE sarcoma after surgical intervention to determine functional mobility. It includes 6 categories: (1) pain; (2) function using Timed Up and Down Stairs (TUDS) time and Timed Up and Go (TUG) time, HR, and RPE are also assessed during the TUDS and TUG; (3) use of assistive devices; (4) satisfaction with walking quality; (5) participation in work, school, sports; and (6) endurance measured by the 9-Minute Walk-Run (9MWR). Physiological cost index (PCI), HR, and RPE were also measured during the 9MWR. The maximum score that can be obtained on the FMA is 70, indicating the best functional outcome (see FMA in the Appendix).
ROM was measured both actively and passively using a goniometer. 16, 17 Measurements included hip flexion and extension, hip abduction and adduction, hip internal and external rotation, knee flexion and extension, and ankle DF and plantar flexion. ROM was attempted on bilateral LEs; however, because of precautions and to prevent injury, the involved extremity may not have been measured.
Strength was measured using a Chatillon MSC-500 hand-held myometer. The strength was measured in Range of motion using a goniometer X X X Strength using a myometer X X X newtons. Strength assessment was measured using the break test. 18 The break test required the participants to hold the extremity after placed in the position below and not allow the examiner to "break" the hold. Hip flexion, knee extension, and ankle DF were tested but only on the unaffected LE. Strength was only obtained in the intervention group.
Statistical Analysis
For demographic and clinical variables, means and standard deviations (SDs) were calculated for continuous variables and 2-samples t tests were conducted to compare the characteristics between participants and controls. Frequencies were calculated for categorical variables, and χ 2 tests were used to assess significance. Multivariable linear regression analysis was used to test the presurgery PT intervention effect on the postsurgery FMA, adjusted for preintervention FMA, sex, age at diagnosis, and surgical procedure. One-sample t tests were applied to compare mean change from zero in strength in the uninvolved extremity from preintervention to presurgery, presurgery to postsurgery, and preintervention to postsurgery, respectively. Statistical significance was predefined at a P value of less than .05, without adjustment for multiple testing. All analyses were conducted in SAS 9.3 (SAS Institute, Cary North Carolina) or StatXact v11.1 (Cytel Inc, Cambridge, Massachusetts).
RESULTS
The characteristics of the study population for each group are depicted in Table 2 . There were no significant differences in demographic variables between the 2 groups except for diagnosis. All participants in the control group had osteosarcoma, and most of the children and/or adolescents in the intervention group had osteosarcoma as well at 78.6%. Mean (SD) ages at time of baseline evaluation were 13.5 (3.5) for the intervention group and 13.1 (3.5) for the control group. More females were in the control group (45.7%) than in the intervention group (28.6%). Most individuals in the intervention and control groups had a limb-sparing procedure of their femur (30.0% and 54.3%, respectively). The involved extremity was nearly equal in terms of laterality in the control group at 51.4% of the left lower extremity (LLE) and 48.6% of the right lower extremity (RLE). The involved extremity in the intervention group was 64.3% affecting the LLE and 35.7% affecting the RLE.
Feasibility
Twelve of the 14 participants (85%) in the intervention group completed at least 50% of their scheduled PT sessions. The other 2 participants attended 43% and 47% of their scheduled sessions. Reasons for not attending sessions included illness, previous appointment ran late, and unknown reasons. 
Physical Performance
After adjusting for age at diagnosis, sex, and surgical procedure, those in the intervention group had a significantly higher score (10 points) on the FMA than those in the control group at 20 to 22 weeks (Table 3) , and the significant difference did not change after adjusting for preintervention FMA total score, sex, age at diagnosis, and surgical procedures (P = .03, data not shown). This was primarily due to their better performance on the 9MWR. When compared with controls, whose FMA scale score on the 9MWR test decreased by 0.7 points, the score of intervention group participants improved by 0.6 points from baseline to 20 to 22 weeks (P = .03, data not shown). Table 4 includes the mean (SD) of ROM measurements for both involved and uninvolved extremity extensions, among both the intervention and control groups at each time point. There were no detectable differences between groups or between extremities within groups at any time point.
Range of Motion
Strength
Strength measures for the intervention group are shown in Table 5 . Strength declined from baseline to postsurgery and did not recover by 20 to 22 weeks in the intervention group.
DISCUSSION
To our knowledge, this is the first study to evaluate the feasibility and initial efficacy of prehabilitation in children, adolescents, and young adults receiving chemotherapy for an LE malignancy and awaiting a limb-sparing procedure or amputation. This pilot study indicates that 85% of children who are awaiting local control while undergoing chemotherapy for an LE malignancy can successfully complete 10 to 12 weeks of prehabilitation and that such a program has potential to significantly improve their physical fitness and functional mobility. We predicted that 60% of individuals would attend at least 50% of their scheduled PT session preoperatively. Eighty-five percent of the intervention group participants completed at least 50% of their preoperative PT. This finding is consistent with another study evaluating functional outcomes after spinal surgery. Nielsen et al 19 found that 85% of the 28 adults in the intervention group were able to complete an 8-week exercise preoperative PT program. Our feasibility outcome was slightly better than one study that recruited 10 men with a diagnosis of prostate cancer to participate in a 6-week, twice-weekly preoperative PT program before undergoing a prostatectomy. 20 They found that 50% of participants completed more than 80% of the 12 training sessions and only 1 missing more than 6 sessions. Of note, the individuals in the aforementioned studies were not receiving chemotherapy during prehabilitation. However, in all studies discussed, there is demonstration of moderate to high probability that individuals can participate in a preoperative PT program.
Predicted maximum HR at 50% to 70% was used for this study along with RPE without any adverse effects in our patient population. This calculation was an easy, safe way to guide treatment and ensure effective cardiovascular training that lead to better functional outcomes in this pilot study. Future studies could compare predicted maximum HR calculation and exercise testing to determine HR range for prehabilitation in this patient population.
Our study found an increase in walking distance on the 9MWR and a higher score on the FMA at weeks 20 to 22 in the intervention group when compared with the control group. Most research on functional outcomes of prehabilitation has been done on individuals awaiting a total hip or knee arthroscopy in the adult population. A literature review performed by Gill and McBurney 21 found that adults who participated in preoperative PT before a total hip replacement surgery had better self-reported function than controls. In one study, 26 individuals 50 years and older participated in prehabilitation before receiving a total knee arthroscopy (TKA). They were compared with 28 individuals who received usual standard of care of postoperative PT. The intervention group on average received 13 sessions preoperatively and exercises consisted of flexibility, resistance, and step training. All individuals were evaluated at baseline, preoperatively, 1 month postoperatively, and 3 months postoperatively. At 1 and 3 months postoperatively, participants in the intervention group demonstrated an improvement in function whereas participants in the control group had a significant decrease in their 6-minute walk distance at 1 month postoperatively. 22 Strength declined in the intervention group overtime, and no change was seen in ROM between groups. A literature review performed by Silkman Baker and McKeon 23 had similar findings in individuals awaiting a TKA. They looked at the geriatric population and determined that individuals who received preoperative PT did not differ from those in the control groups in terms of strength and ROM.
Future research should examine whether there is a difference in strength of the uninvolved extremity between individuals who received preoperative PT and those who did not. Our study did not have strength measurements for the control group; therefore, we were unable to compare the 2 groups. While our study showed a decline in strength from baseline to weeks 20 to 22, it is possible the decline was not as severe as it could have been if PT was not administered before surgery. Another limitation of the study was that the 2 groups were treated at different time periods, PTSARC from 2012 to 2016 and OS2008 from 2008 to 2012. Since previous studies have determined long-term functional deficits and decreased physical fitness, it would be of importance if future research would perform an evaluation several years postoperatively to determine longterm effects when a preoperative PT program was administered. Finally, a randomized controlled trial with larger sample sizes should be performed to strengthen the argument to administer PT before local control while undergoing chemotherapy.
CONCLUSION
It is well documented that lasting functional deficits occur as a result of a local control and chemotherapy. [1] [2] [3] [4] 24 By adding a prehabilitation regimen to those awaiting a limb-sparing procedure or amputation while undergoing chemotherapy, it is possible to negate or lessen the functional deficits found in these individuals. Ongoing investigations into comparing strength between groups and longer follow-up times to determine whether function and physical fitness are maintained overtime are warranted.
